Day One Biopharmaceuticals

👥 11-50💰 $150.0m Post-IPO Equity on 2023-06-06PharmaceuticalBiotechnologyBiopharmaHealth Care
Website LinkedIn Email Phone # Twitter

Day One Biopharmaceuticals is a biotechnology company dedicated to developing innovative cancer therapies for patients of all ages, focusing on the unique needs of both children and adults. By leveraging advances in cancer research, the company aims to bring effective treatments to market quickly for families facing cancer diagnoses, while prioritizing collaborations with research institutions and other biotech firms.

Related companies: